z-logo
open-access-imgOpen Access
Effect of Anthrax Immune Globulin on Response to BioThrax (Anthrax Vaccine Adsorbed) in New Zealand White Rabbits
Author(s) -
Nina Malkevich,
Subhendu Basu,
Thomas L. Rudge,
Kristin H. Clement,
Ajoy C. Chakrabarti,
Ronald T. Aimes,
Gary S. Nabors,
Mario H. Skiadopoulos,
Б. И. Ионин
Publication year - 2013
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00460-13
Subject(s) - anthrax vaccines , immune system , vaccination , immunology , antibody , virology , antigen , antibody response , anthrax toxin , microbiology and biotechnology , medicine , biology , immunization , dna vaccination , biochemistry , fusion protein , gene , recombinant dna
Development of anthrax countermeasures that may be used concomitantly in a postexposure setting requires an understanding of the interaction between these products. Anthrax immune globulin intravenous (AIGIV) is a candidate immunotherapeutic that contains neutralizing antibodies against protective antigen (PA), a component of anthrax toxins. We evaluated the interaction between AIGIV and BioThrax (anthrax vaccine adsorbed) in rabbits. While pharmacokinetics of AIGIV were not altered by vaccination, the vaccine-induced immune response was abrogated in AIGIV-treated animals.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom